Search
Home
Publications
About us
Activities
English
Search
Deliberate Release
20.08.2021
Advice following the European consultation on the authorisation process of GMOs in medical applications
CGM/210820-01
Advisory reports
24.03.2021
Generic environmental risk assessment of replication-deficient adenoviral vectors in clinical trials
210324-02
Advisory reports
24.03.2021
Generic environmental risk assessment of clinical trials with MVA vectors
CGM/210324-01
Advisory reports
11.12.2020
Plant material inactivation
CGM 2020-05
Research reports
10.10.2019
No rose without thorns
CGM/191010-01
Policy reports
17.12.2015
Testing impacts of toxic compounds from transgenic crops on non-target arthropods in tier-1 studies: exposure and response
CGM 2015-08
Research reports
10.11.2014
Research report Survey of Field trials with Genetically Modified Plants – Global trends and developments
CGM 2014-04
Research reports
26.09.2013
Abstract of COGEM advisory reports on the application for a clinical trial testing recombinant Vaccinia virus- en Fowlpox virus- vaccine in patients with prostate cancer
CGM/130926-01
Advisory reports
27.02.2013
Criteria for the molecular characterisation of GMOs for medical and veterinary applications
CGM/130227-05
Advisory reports
27.11.2012
The use of statistical tools in field testing for effects of GM plants on non-target organisms (NTOs)
CGM 2012-06
Research reports
30.10.2012
Gene therapy clinical trials: what about the environment? A comparison between the Netherlands and North America
CGM 2012-07
Research reports
14.05.2012
The possible role of honeybees in the spread of pollen from field trials
CGM 2012-02
Research reports
